Predicting paediatric pneumonia severity in the emergency department: a multinational prospective cohort study of the Pediatric Emergency Research Network
Todd A Florin MD , Prof Daniel J Tancredi PhD , Lilliam Ambroggio PhD , Prof Franz E Babl MD , Prof Stuart R Dalziel PhD , Michelle Eckerle MD , Prof Santiago Mintegi PhD , Prof Mark I Neuman MD , Prof Amy C Plint MD , Norma-Jean Simon MPH , Prof Nathan Kuppermann MD
{"title":"Predicting paediatric pneumonia severity in the emergency department: a multinational prospective cohort study of the Pediatric Emergency Research Network","authors":"Todd A Florin MD , Prof Daniel J Tancredi PhD , Lilliam Ambroggio PhD , Prof Franz E Babl MD , Prof Stuart R Dalziel PhD , Michelle Eckerle MD , Prof Santiago Mintegi PhD , Prof Mark I Neuman MD , Prof Amy C Plint MD , Norma-Jean Simon MPH , Prof Nathan Kuppermann MD","doi":"10.1016/S2352-4642(25)00094-X","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Risk stratification tools for paediatric community-acquired pneumonia (CAP) in well-resourced settings are scarce. We prospectively developed models to predict CAP severity within a multinational cohort of paediatric emergency departments (EDs). Our primary objective was to develop a risk prediction model to discriminate between mild CAP and moderate or severe CAP to assist clinicians in determining the need for hospitalisation.</div></div><div><h3>Methods</h3><div>This prospective cohort study was conducted from Feb 6, 2019, to June 30, 2021, at 73 EDs in 14 countries. Children aged 3 months to <14 years with clinical diagnoses of CAP were included. Children were excluded if they were recently hospitalised or had a chronic complex condition (eg, immunodeficiency). The primary outcome was severity, defined as mild (CAP treated in the outpatient setting or hospitalisation <24 h with no use of oxygen or intravenous fluids during that time), moderate (hospitalisation <24 h with oxygen or fluids, or hospitalisation ≥24 h regardless of interventions but without an outcome qualifying as severe CAP), or severe (chest drainage, intensive care unit admission >24 h, positive-pressure ventilation, septic shock, vasoactive infusions, extracorporeal membrane oxygenation, or death) occurring within 7 days of the ED visit. Models were developed using logistic regression with bootstrap validation.</div></div><div><h3>Findings</h3><div>Of 2222 children in the overall study population (1103 [49·7%] female, 1119 [50·3%] male; median age 3 years [IQR 1–5]), 1290 (58·1%) had mild CAP, 812 (36·5%) moderate, and 120 (5·4%) severe. Primary analyses were performed in 1901 patients with complete data: 1011 (53·2%) mild, 772 (40·6%) moderate, and 118 (6·2%) severe CAP. Congestion or rhinorrhoea was negatively associated with moderate or severe CAP (adjusted odds ratio 0·59 [95% CI 0·46–0·76]), while abdominal pain (1·52 [1·17–1·97]), refusal to drink (1·57 [1·24–2·00]), antibiotics before ED visit (1·64 [1·29–2·10]), chest retractions (2·86 [2·24–3·65]), respiratory rate above the 95th percentile for age (1·63 [1·29–2·06]), heart rate above the 95th percentile for age (1·64 [1·27–2·12]), and hypoxaemia (oxygen saturation 90–92%, 3·24 [2·46–4·27]; <90%, 13·39 [8·64–20·73]) were positively associated. The model accurately discriminated between mild CAP and moderate or severe CAP (c-statistic 0·82 [95% CI 0·80–0·84]). Similar results were found in those with radiographic CAP, with decreased breath sounds and multifocal opacities on radiography as additional predictors (c-statistic 0·82 [0·80–0·85]).</div></div><div><h3>Interpretation</h3><div>We developed accurate, pragmatic severity risk prediction models among children with CAP. After future external validation, these models have the potential to provide individualised risk assessments that can be incorporated into clinical judgement in well-resourced health systems to improve management.</div></div><div><h3>Funding</h3><div>Division of Emergency Medicine at Cincinnati Children's Hospital Medical Center, Division of Emergency Medicine at Ann & Robert H. Lurie Children's Hospital of Chicago, and Department of Emergency Medicine at University of California, Davis.</div></div>","PeriodicalId":54238,"journal":{"name":"Lancet Child & Adolescent Health","volume":"9 6","pages":"Pages 383-392"},"PeriodicalIF":19.9000,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lancet Child & Adolescent Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S235246422500094X","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Risk stratification tools for paediatric community-acquired pneumonia (CAP) in well-resourced settings are scarce. We prospectively developed models to predict CAP severity within a multinational cohort of paediatric emergency departments (EDs). Our primary objective was to develop a risk prediction model to discriminate between mild CAP and moderate or severe CAP to assist clinicians in determining the need for hospitalisation.
Methods
This prospective cohort study was conducted from Feb 6, 2019, to June 30, 2021, at 73 EDs in 14 countries. Children aged 3 months to <14 years with clinical diagnoses of CAP were included. Children were excluded if they were recently hospitalised or had a chronic complex condition (eg, immunodeficiency). The primary outcome was severity, defined as mild (CAP treated in the outpatient setting or hospitalisation <24 h with no use of oxygen or intravenous fluids during that time), moderate (hospitalisation <24 h with oxygen or fluids, or hospitalisation ≥24 h regardless of interventions but without an outcome qualifying as severe CAP), or severe (chest drainage, intensive care unit admission >24 h, positive-pressure ventilation, septic shock, vasoactive infusions, extracorporeal membrane oxygenation, or death) occurring within 7 days of the ED visit. Models were developed using logistic regression with bootstrap validation.
Findings
Of 2222 children in the overall study population (1103 [49·7%] female, 1119 [50·3%] male; median age 3 years [IQR 1–5]), 1290 (58·1%) had mild CAP, 812 (36·5%) moderate, and 120 (5·4%) severe. Primary analyses were performed in 1901 patients with complete data: 1011 (53·2%) mild, 772 (40·6%) moderate, and 118 (6·2%) severe CAP. Congestion or rhinorrhoea was negatively associated with moderate or severe CAP (adjusted odds ratio 0·59 [95% CI 0·46–0·76]), while abdominal pain (1·52 [1·17–1·97]), refusal to drink (1·57 [1·24–2·00]), antibiotics before ED visit (1·64 [1·29–2·10]), chest retractions (2·86 [2·24–3·65]), respiratory rate above the 95th percentile for age (1·63 [1·29–2·06]), heart rate above the 95th percentile for age (1·64 [1·27–2·12]), and hypoxaemia (oxygen saturation 90–92%, 3·24 [2·46–4·27]; <90%, 13·39 [8·64–20·73]) were positively associated. The model accurately discriminated between mild CAP and moderate or severe CAP (c-statistic 0·82 [95% CI 0·80–0·84]). Similar results were found in those with radiographic CAP, with decreased breath sounds and multifocal opacities on radiography as additional predictors (c-statistic 0·82 [0·80–0·85]).
Interpretation
We developed accurate, pragmatic severity risk prediction models among children with CAP. After future external validation, these models have the potential to provide individualised risk assessments that can be incorporated into clinical judgement in well-resourced health systems to improve management.
Funding
Division of Emergency Medicine at Cincinnati Children's Hospital Medical Center, Division of Emergency Medicine at Ann & Robert H. Lurie Children's Hospital of Chicago, and Department of Emergency Medicine at University of California, Davis.
期刊介绍:
The Lancet Child & Adolescent Health, an independent journal with a global perspective and strong clinical focus, presents influential original research, authoritative reviews, and insightful opinion pieces to promote the health of children from fetal development through young adulthood.
This journal invite submissions that will directly impact clinical practice or child health across the disciplines of general paediatrics, adolescent medicine, or child development, and across all paediatric subspecialties including (but not limited to) allergy and immunology, cardiology, critical care, endocrinology, fetal and neonatal medicine, gastroenterology, haematology, hepatology and nutrition, infectious diseases, neurology, oncology, psychiatry, respiratory medicine, and surgery.
Content includes articles, reviews, viewpoints, clinical pictures, comments, and correspondence, along with series and commissions aimed at driving positive change in clinical practice and health policy in child and adolescent health.